Scinai Immunotherapeutics (SCNI) Stock: Why It Moved Today
Updated Oct 19, 2026, 4:00 PM ET · closing price
- Closed at $0.75, -0.27% vs the prior close of $0.75.
- Volume 109.08K shares, 0.0x its 50-day average (light).
- New SEC filings: 6-K (Oct 16, 2026).
- No new insider buys or sales reported since the prior session.
SCNI ends flat (-0.3%) to $0.75, a 52-week low. Closed at $0.75, -0.27% vs the prior close of $0.75. Day range $0.66–$0.75, opened at $0.75.
SCNI daily analysis — what happened
A plain-English, data-only note for every US trading day (today's note updates every 2 hours while the market is open). Newest first; older days stay archived below.
Oct 19, 2026 — SCNI ends flat (-0.3%) to $0.75, a 52-week low
- Closed at $0.75, -0.27% vs the prior close of $0.75. Day range $0.66–$0.75, opened at $0.75.
- Volume was 109.08K shares, 0.0x its 50-day average of 2.73M — lighter than usual.
- Price is -60.1% vs its 50-day average ($1.88) and -84.4% vs its 200-day average ($4.80).
- 52-week range $0.66–$15.50; today's close sits at 1% of that range, 95.2% below the 52-week high.
Oct 16, 2026 — SCNI slides 16.6% to $0.75, a 52-week low
- Closed at $0.75, -16.59% vs the prior close of $0.90. Day range $0.73–$0.90, opened at $0.83.
- Volume was 218.49K shares, 0.1x its 50-day average of 2.72M — lighter than usual.
- Price is -60.7% vs its 50-day average ($1.91) and -84.4% vs its 200-day average ($4.83).
- 52-week range $0.73–$15.65; today's close sits at 0% of that range, 95.2% below the 52-week high.
Oct 15, 2026 — SCNI rises 2.5% to $0.90
- Closed at $0.90, +2.50% vs the prior close of $0.88. Day range $0.76–$0.94, opened at $0.79.
- Volume was 372.40K shares, 0.1x its 50-day average of 2.71M — lighter than usual.
- Price is -53.7% vs its 50-day average ($1.95) and -81.4% vs its 200-day average ($4.86).
- 52-week range $0.75–$15.65; today's close sits at 1% of that range, 94.2% below the 52-week high.
- SEC filings that day: 6-K.
Oct 14, 2026 — SCNI slides 28.5% to $0.88, a 52-week low
- Closed at $0.88, -28.46% vs the prior close of $1.23. Day range $0.75–$0.95, opened at $0.78.
- Volume was 2.72M shares, 1.0x its 50-day average of 2.66M.
- Price is -55.6% vs its 50-day average ($1.98) and -82.0% vs its 200-day average ($4.89).
- 52-week range $0.75–$15.65; today's close sits at 1% of that range, 94.4% below the 52-week high.
Oct 13, 2026 — SCNI jumps 6.0% to $1.23 on 46.1x normal volume
- Closed at $1.23, +6.03% vs the prior close of $1.16. Day range $1.14–$1.76, opened at $1.56.
- Volume was 64.10M shares, 46.1x its 50-day average of 1.39M — unusually heavy trading.
- Price is -38.9% vs its 50-day average ($2.01) and -75.0% vs its 200-day average ($4.92).
- 52-week range $1.06–$15.65; today's close sits at 1% of that range, 92.1% below the 52-week high.
- SEC filings that day: 6-K.
Oct 12, 2026 — SCNI dips 1.7% to $1.16
- Closed at $1.16, -1.69% vs the prior close of $1.18. Day range $1.11–$1.20, opened at $1.18.
- Volume was 42.50K shares, 0.0x its 50-day average of 1.39M — lighter than usual.
- Price is -43.2% vs its 50-day average ($2.04) and -76.6% vs its 200-day average ($4.95).
- 52-week range $1.06–$15.65; today's close sits at 1% of that range, 92.6% below the 52-week high.
Oct 9, 2026 — SCNI dips 2.5% to $1.18
- Closed at $1.18, -2.48% vs the prior close of $1.21. Day range $1.18–$1.23, opened at $1.22.
- Volume was 19.20K shares, 0.0x its 50-day average of 1.39M — lighter than usual.
- Price is -43.1% vs its 50-day average ($2.07) and -76.3% vs its 200-day average ($4.98).
- 52-week range $1.06–$15.80; today's close sits at 1% of that range, 92.5% below the 52-week high.
Oct 8, 2026 — SCNI jumps 7.1% to $1.21
- Closed at $1.21, +7.08% vs the prior close of $1.13. Day range $1.06–$1.23, opened at $1.11.
- Volume was 89.30K shares, 0.1x its 50-day average of 1.39M — lighter than usual.
- Price is -42.6% vs its 50-day average ($2.11) and -75.9% vs its 200-day average ($5.02).
- 52-week range $1.06–$16.30; today's close sits at 1% of that range, 92.6% below the 52-week high.
Oct 7, 2026 — SCNI slides 7.4% to $1.13, a 52-week low, 3 down days in a row
- Closed at $1.13, -7.38% vs the prior close of $1.22. Day range $1.12–$1.23, opened at $1.20.
- Volume was 39.80K shares, 0.0x its 50-day average of 1.39M — lighter than usual.
- Price is -47.1% vs its 50-day average ($2.14) and -77.6% vs its 200-day average ($5.05).
- 52-week range $1.12–$16.30; today's close sits at 0% of that range, 93.1% below the 52-week high.
- That makes 3 straight losses.
Oct 6, 2026 — SCNI slides 3.2% to $1.22, a 52-week low
- Closed at $1.22, -3.17% vs the prior close of $1.26. Day range $1.22–$1.29, opened at $1.26.
- Volume was 42.70K shares, 0.0x its 50-day average of 1.39M — lighter than usual.
- Price is -43.7% vs its 50-day average ($2.17) and -76.0% vs its 200-day average ($5.08).
- 52-week range $1.22–$16.30; today's close sits at 0% of that range, 92.5% below the 52-week high.
Oct 5, 2026 — SCNI slides 5.3% to $1.26, a 52-week low
- Closed at $1.26, -5.26% vs the prior close of $1.33. Day range $1.26–$1.36, opened at $1.33.
- Volume was 37.60K shares, 0.0x its 50-day average of 1.39M — lighter than usual.
- Price is -42.5% vs its 50-day average ($2.19) and -75.4% vs its 200-day average ($5.12).
- 52-week range $1.26–$16.30; today's close sits at 0% of that range, 92.3% below the 52-week high.
Oct 2, 2026 — SCNI rises 1.5% to $1.33
- Closed at $1.33, +1.53% vs the prior close of $1.31. Day range $1.30–$1.37, opened at $1.30.
- Volume was 22.10K shares, 0.0x its 50-day average of 1.39M — lighter than usual.
- Price is -39.9% vs its 50-day average ($2.21) and -74.2% vs its 200-day average ($5.15).
- 52-week range $1.27–$16.30; today's close sits at 0% of that range, 91.8% below the 52-week high.
SCNI bull case vs bear case (from the data)
- No clear positive signal in the price trend, filings or insider data right now.
- Price is -60.1% vs its 50-day average — short-term trend is down.
- Price is -84.4% vs its 200-day average — below the long-term trend line.
- Latest fiscal-year net income: loss of $5.80M.
- High volatility: average daily move of 7.0% over 20 sessions.
SCNI latest news & SEC filings
Every SEC filing by or about SCNI in the last 120 days, explained in plain English. Updated daily, with a same-day refresh for new filings.
Oct 16, 2026 · Form 6-K — Report from a foreign company (6-K)
Report from a foreign company (6-K) — news it published at home
Oct 15, 2026 · Form 6-K — Report from a foreign company (6-K)
Report from a foreign company (6-K) — news it published at home
Oct 13, 2026 · Form 6-K — Report from a foreign company (6-K)
Report from a foreign company (6-K) — news it published at home
Sep 24, 2026 · Form F-1 — F-1 filing
F-1 filing
An offering document: new shares or debt may be sold, which can increase the share count (dilution) or debt load. Size and terms are in the prospectus.
Sep 21, 2026 · Form 6-K — Report from a foreign company (6-K)
Report from a foreign company (6-K) — news it published at home
Sep 8, 2026 · Form 6-K — Report from a foreign company (6-K)
Report from a foreign company (6-K) — news it published at home
Aug 28, 2026 · Form EFFECT — EFFECT filing
EFFECT filing
Aug 27, 2026 · Form POS AM — POS AM filing
POS AM filing
Aug 26, 2026 · Form 6-K — Report from a foreign company (6-K)
Report from a foreign company (6-K) — news it published at home
Aug 19, 2026 · Form 6-K — Report from a foreign company (6-K)
Report from a foreign company (6-K) — news it published at home
Jul 9, 2026 · Form SCHEDULE 13G/A — Update to a passive 5%+ stake (13G)
Update to a passive 5%+ stake (13G)
Filed by an outside investor (not the company). It reports a holding of more than 5% of a share class; percentage and holder name are in the filing.
Jul 1, 2026 · Form SCHEDULE 13G/A — Update to a passive 5%+ stake (13G)
Update to a passive 5%+ stake (13G)
Filed by an outside investor (not the company). It reports a holding of more than 5% of a share class; percentage and holder name are in the filing.
Things to know before you trade SCNI
- How much it moves: over the last 20 sessions the average daily move was 6.98% (largest 28.5%). That is a volatile stock.
- Liquidity: about 3.48M shares (≈$2.61M) trade per day on average.
- 52-week position: $0.75 vs a range of $0.66–$15.50 (1% of the range).
- Dividends: no cash dividends in the last 2 years.
- Splits: 1:10 on Aug 21, 2026
- Insider trades (Form 4, last 12 months, recent 25 shown): 0 open-market buys, 0 sales.
- Latest filings: 6-K Oct 16, 2026; 6-K Oct 15, 2026; 6-K Oct 13, 2026.
- Listing: Nasdaq · industry: Biological Products, (No Diagnostic Substances).
SCNI market data (last 20 sessions)
| Date | Open | High | Low | Close | Volume |
|---|---|---|---|---|---|
| Oct 19, 2026 | 0.75 | 0.75 | 0.66 | 0.75 | 109.08K |
| Oct 16, 2026 | 0.83 | 0.90 | 0.73 | 0.75 | 224.70K |
| Oct 15, 2026 | 0.79 | 0.94 | 0.76 | 0.90 | 372.40K |
| Oct 14, 2026 | 0.78 | 0.95 | 0.75 | 0.88 | 2.72M |
| Oct 13, 2026 | 1.56 | 1.76 | 1.14 | 1.23 | 64.10M |
| Oct 12, 2026 | 1.18 | 1.20 | 1.11 | 1.16 | 42.50K |
| Oct 9, 2026 | 1.22 | 1.23 | 1.18 | 1.18 | 19.20K |
| Oct 8, 2026 | 1.11 | 1.23 | 1.06 | 1.21 | 89.30K |
| Oct 7, 2026 | 1.20 | 1.23 | 1.12 | 1.13 | 39.80K |
| Oct 6, 2026 | 1.26 | 1.29 | 1.22 | 1.22 | 42.70K |
| Oct 5, 2026 | 1.33 | 1.36 | 1.26 | 1.26 | 37.60K |
| Oct 2, 2026 | 1.30 | 1.37 | 1.30 | 1.33 | 22.10K |
| Oct 1, 2026 | 1.39 | 1.45 | 1.27 | 1.31 | 42.10K |
| Sep 30, 2026 | 1.36 | 1.42 | 1.32 | 1.42 | 79.50K |
| Sep 29, 2026 | 1.50 | 1.50 | 1.35 | 1.41 | 97.50K |
| Sep 28, 2026 | 1.55 | 1.57 | 1.43 | 1.47 | 67.40K |
| Sep 25, 2026 | 1.72 | 1.73 | 1.55 | 1.55 | 119.80K |
| Sep 24, 2026 | 1.91 | 1.94 | 1.81 | 1.86 | 165.70K |
| Sep 23, 2026 | 1.76 | 2.08 | 1.69 | 1.98 | 517.40K |
| Sep 22, 2026 | 1.61 | 1.93 | 1.57 | 1.91 | 661.20K |
About Scinai Immunotherapeutics
Scinai Immunotherapeutics (SCNI) is listed on the Nasdaq and classified by the SEC under “Biological Products, (No Diagnostic Substances)”. Its business address is in JERUSALEM, Israel. State of incorporation: Israel. Fiscal year ends December 31. SEC CIK 1611747.
SCNI board of directors & executives
From SEC Form 3/4/5 insider filings made in the last 12 months (date = latest filing).
Directors
| Name | Role | Latest filing |
|---|---|---|
| Uri Ben-Or | Director | Mar 18, 2026 |
| Mark Germain | Director | Jun 18, 2026 |
| Jay Green | Director | Mar 18, 2026 |
| Yael Margolin | Director | Mar 18, 2026 |
| Samuel J Moed | Director | Mar 18, 2026 |
| Adi Raviv | Director | Mar 18, 2026 |
| Amir Reichman | Chief Executive Officer | Jun 18, 2026 |
Executive officers
| Name | Title | Latest filing |
|---|---|---|
| Elad Mark | Chief Operating Officer | Mar 26, 2026 |
| Amir Reichman | Chief Executive Officer | Jun 18, 2026 |
Recent insider buys & sales
| Date | Insider | Type | Shares | Price |
|---|---|---|---|---|
| No open-market insider buys or sales reported in the last 12 months. | ||||
SCNI financials (annual, from XBRL filings)
| Fiscal year end | Revenue | Net income | Diluted EPS | Operating cash flow |
|---|---|---|---|---|
| Dec 31, 2022 | — | $-5.80M | -0.01 | $-7.26M |
| Dec 31, 2021 | — | $-8.21M | -0.02 | $-7.43M |
Latest balance sheet: total assets $23.29M, total liabilities $—, cash $10.80M (as of Mar 31, 2023).
SCNI earnings / results-day log
| Date | Filing | Close that day |
|---|---|---|
| No 8-K earnings releases in recent filings. | ||
Related stocks · Biological Products, (No Diagnostic Substances)
Moderna (MRNA)Amgen (AMGN)Gilead Sciences (GILD)Twist Bioscience (TWST)Revolution Medicines (RVMD)Argenx Se (ARGX)Kodiak Sciences (KOD)Biogen (BIIB)Halozyme Therapeutics (HALO)Vaxcyte (PCVX)
Popular today
Spdr S&P 500 Etf (SPY)Micron Technology (MU)Nvidia (NVDA)Meta Platforms (META)Sandisk (SNDK)Space Exploration Technologies (SPCX)Tesla (TSLA)Apple (AAPL)AMD (AMD)Microsoft (MSFT)Intel (INTC)Amazon (AMZN)
More on SCNI
Information only, not investment advice. BuyMeWhiskey is not a registered investment adviser or broker-dealer; nothing here is a recommendation to buy, sell or hold any security, and there are no price targets. Data comes from SEC EDGAR filings and public end-of-day market data and may be delayed or contain errors. Verify with the company's filings before making decisions. Prices: end-of-day data as of Oct 19, 2026, 4:00 PM ET. Filings: SEC EDGAR. Refreshed every 2 hours during US market hours.